Diagnostic Imaging Devices - Bahrain

  • Bahrain
  • The Diagnostic Imaging Devices market market in Bahrain is anticipated to achieve a revenue of US$21.05m in the year 2024.
  • It is expected that the revenue will exhibit a compound annual growth rate (CAGR) of 4.74% between 2024 and 2029, leading to a market volume of US$26.53m by 2029.
  • When comparing globally, the United States is projected to generate the highest revenue in this market, with an estimated value of US$11,930.00m in 2024.
  • Bahrain's increasing investments in advanced diagnostic imaging devices reflect its commitment to enhancing healthcare services.

Key regions: Germany, Japan, Netherlands, Spain, United States

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Diagnostic Imaging Devices market in Bahrain is experiencing steady growth due to increasing customer preferences for advanced medical technology, the emergence of new trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Bahrain are leaning towards diagnostic imaging devices that offer high-quality imaging capabilities, faster scanning times, and improved patient comfort. This preference is driven by the increasing demand for accurate and timely diagnoses, as well as the desire to minimize patient discomfort during medical procedures. As a result, there is a growing demand for advanced imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound devices. Trends in the market indicate a shift towards more portable and compact diagnostic imaging devices. This trend is driven by the need for greater accessibility to medical services, especially in remote areas or regions with limited healthcare infrastructure. Portable imaging devices allow healthcare providers to bring diagnostic services closer to patients, improving patient outcomes and reducing the need for travel. Additionally, advancements in technology have enabled the development of smaller and more efficient imaging devices, making them more suitable for point-of-care diagnostics. Local special circumstances in Bahrain, such as a growing aging population and an increasing prevalence of chronic diseases, are contributing to the growth of the Diagnostic Imaging Devices market. As the population ages, the demand for diagnostic imaging devices is expected to rise, as older individuals are more prone to developing health conditions that require medical imaging. Furthermore, the increasing prevalence of chronic diseases, such as cardiovascular diseases and cancer, necessitates regular monitoring and imaging for accurate diagnosis and treatment planning. Underlying macroeconomic factors, such as government investments in healthcare infrastructure and rising healthcare expenditure, are also driving the growth of the Diagnostic Imaging Devices market in Bahrain. The government of Bahrain has been investing in the development of healthcare facilities and infrastructure, including the establishment of specialized medical centers and hospitals. This investment aims to improve the accessibility and quality of healthcare services for the population. Additionally, rising healthcare expenditure, fueled by increasing healthcare needs and a growing population, is creating a favorable market environment for diagnostic imaging device manufacturers and suppliers. In conclusion, the Diagnostic Imaging Devices market in Bahrain is experiencing growth due to customer preferences for advanced medical technology, the emergence of new trends in the market, local special circumstances, and underlying macroeconomic factors. The demand for high-quality imaging capabilities, portable devices, and improved patient comfort is driving the market forward. Additionally, the aging population, increasing prevalence of chronic diseases, government investments in healthcare infrastructure, and rising healthcare expenditure are contributing to the market's growth.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)